. The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J Biol Chem. 1998 Nov 6;273(45):29719-26. PubMed.


Please login to recommend the paper.


  1. This paper offers an interesting idea for future strategies of AD therapy which could exploit the HHQK sequence to block plaque-induced microgliosis in AD.

Make a Comment

To make a comment you must login or register.